MILPITAS, Calif.—The American Association for Laboratory Accreditation (A2LA) has awarded accreditation to Spectra Laboratories' Milpitas, Calif. facility.
The accreditation is in accordance with stringent international requirements of ISO 15189:2007 Medical Laboratories – Particular requirements for quality and competence.
This is the second ISO 15189 accreditation from A2LA to be earned by a medical testing laboratory in the United States. The first ISO 15189 accreditation from A2LA was awarded to Spectra’s partner laboratory in Rockleigh, N.J., on May 20, 2010. Spectra Laboratories is a unit of Fresenius Medical Care North America.
By fulfilling A2LA’s ISO 15189 requirements, Spectra has demonstrated its ability to meet both the technical competence and quality system requirements that are necessary to consistently deliver timely and reliable results. Furthermore, this internationally-recognized accreditation demonstrates that Spectra has established benchmarks for performance and has standardized its operational processes and procedures to best meet the needs of its clients.
“We are very pleased to be once again awarded the A2LA ISO 15189 accreditation," said Nicholas Brownlee, president, Spectra Laboratories. "It reinforces our ongoing commitment to delivering high quality services that are seamless across both our Rockleigh and Milpitas laboratories. We believe that the ISO 15189 accreditation through A2LA further validates our market leadership position as a clinical laboratory service provider and increases our visibility within the international healthcare community.”
A2LA is a nonprofit, non-governmental, public service, membership society, whose stated mission is “to provide comprehensive accreditation services for laboratories, inspection bodies, proficiency testing providers, and reference material producers.”
